Showing 1261-1270 of 3079 results for "".
Optimizing Wound Healing for Cosmetic and Medical Dermatologic Procedures
https://practicaldermatology.com/topics/practice-management/optimizing-wound-healing-for-cosmetic-and-medical-dermatologic-procedures/20522/Among the options for wound management is hypochlorous acid, a broad-action antimicrobial and anti-inflammatory agent.Diagnosing and Managing Acne in Pre-Adolescent and Adolescent Patients
https://practicaldermatology.com/issues/supplements/diagnosing-and-managing-acne-in-pre-adolescent-and-adolescent-patients/23418/How to overcome challenges to effective care.Data Show Impact of Dupilumab on Patients with Coexistent Atopic Diseases
https://practicaldermatology.com/topics/practice-management/data-show-impact-of-dupilumab-on-patients-with-coexistent-atopic-diseases/23477/The Shape of the Contouring Market: Expert Tips on Energy-based Body Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-shape-of-the-contouring-market-expert-tips-on-energy-based-body-treatments/20332/Experienced clinicians weigh in on their approach to identifying, educating, and treating patients for body contouring.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20813/Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicOn the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In tDr. Ross Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-ross-discusses-experience-with-gemini-laser/19470/“There are a lot of new technologies out there, but one of the tried-and-true technologies is KTP laser and the long-pulse YAG laser. And the Gemini fits the bill for both of those wavelengths. So in a sense the Gemini is a time-tested product. It has served us well at our clinic, both at the NavyImproving Dermatologic Care and Access for Gender and Sexual Minority Patients
https://practicaldermatology.com/conferences/aad-2021/improving-dermatologic-care-and-access-for-gender-and-sexual-minority-patients/19919/Dermatologists need increased knowledge of health disparities and tools to best meet the needs of sexual and gender minority patients. From increased risk of skin cancer in sexual minority individuals to acne in the transgender population, there are many dermatologic concerns arising for patients, sAbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society an